What is Vaccine Maitri?
Historical Background
Key Points
11 points- 1.
Vaccine Maitri represents India's commitment to global health solidarity, where it supplied domestically manufactured COVID-19 vaccines, primarily Covishield and Covaxin, to numerous countries across the globe.
- 2.
The initiative operated through multiple channels, including direct bilateral grants to friendly nations, commercial sales agreements, and contributions to the COVAX facility, ensuring a broad reach and flexible delivery mechanisms.
- 3.
A core motivation behind Vaccine Maitri was to address vaccine inequity, particularly in developing countries that lacked the resources or manufacturing capabilities to secure sufficient vaccine doses for their populations.
- 4.
India's role as the 'Pharmacy of the World' was significantly highlighted, demonstrating its capacity not only to produce vaccines at scale but also to share them as a global public good.
Visual Insights
Vaccine Maitri: India's Journey in Global Health Diplomacy
This timeline outlines the key phases of India's Vaccine Maitri initiative, from its launch to its evolution into broader health infrastructure support, demonstrating India's commitment to global health solidarity.
Vaccine Maitri was a critical response to global vaccine inequity during the COVID-19 pandemic, showcasing India's capacity as a global pharmaceutical hub and its commitment to South-South cooperation. Its evolution reflects a broader shift towards comprehensive health diplomacy and strengthening health systems worldwide.
- Late 2020 / Early 2021COVID-19 vaccines become available globally, but many developing nations face access challenges.
- January 2021Vaccine Maitri initiative launched by India, supplying COVID-19 vaccines as grants and commercial sales, starting with Bhutan and Maldives.
- April 2021Temporary halt of vaccine exports under Vaccine Maitri due to a severe domestic surge in COVID-19 cases in India.
- Late 2021Vaccine exports under Vaccine Maitri resumed, reaffirming India's commitment to global vaccine equity and COVAX facility.
- 2024India announced collaboration with Pacific Island Countries (PICs) to develop a comprehensive health infrastructure plan, supported by WHO, extending the 'Maitri' spirit.
- March 2026
Recent Real-World Examples
1 examplesIllustrated in 1 real-world examples from Mar 2026 to Mar 2026
Source Topic
India to Collaborate on Health Infrastructure Plan for Pacific Nations
International RelationsUPSC Relevance
Frequently Asked Questions
61. In an MCQ about Vaccine Maitri, what is a common trap regarding its launch and the temporary halt, and how can aspirants avoid confusing them?
A common trap is confusing the *launch date* (January 2021) with the *temporary halt* (April 2021) or its *resumption* (late 2021). Examiners often test the sequence or specific timing. Another trap is to overemphasize commercial sales as the primary goal, whereas the core objective was humanitarian aid and addressing global vaccine inequity, especially for developing nations.
Exam Tip
Remember 'J-A-L' for January (Launch), April (Halt), Late (Resumption). Also, prioritize 'humanitarian aid' over 'commercial gain' for its core objective.
2. Beyond just supplying vaccines, what specific global problem did Vaccine Maitri aim to solve, especially for developing nations, and why was India uniquely positioned to lead this?
Vaccine Maitri primarily aimed to address the severe *global inequity in vaccine access*, particularly for developing nations that lacked manufacturing capacity or procurement power. Many rich countries had pre-booked large quantities, leaving poorer nations vulnerable. India was uniquely positioned due to its status as the 'Pharmacy of the World' and the *world's largest vaccine producer*, possessing the robust pharmaceutical industry and production capacity to manufacture vaccines at scale and share them as a global public good.
